CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria

Archives of Microbiology · Published 2026-08-05 · DOI 10.1007/s00203-026-05118-8

Authors (6)

Akmal Zubair, Md Abu Kawsar Prodhan Hemal, Alaeldeen Ahmed, Faisal Ahmad, Yasir Waheed, Naila Afghan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zubair, A., Hemal, M., Ahmed, A., et al. (2026). CRISPR/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria. Archives of Microbiology. https://doi.org/10.1007/s00203-026-05118-8

Related articles